Synonyms: QAX-576 | QAX576
Compound class:
Antibody
Comment: Dectrekumab is a fully human investigational anti-interleukin 13 (IL-13) monoclonal antibody, with anti-inflammatory potential.
Peptide sequence and secondary structural information are available from dectrekumab's IMGT/mAb-DB record. Peptide sequences for the heavy and light chains of dectrekumab match those provided in patent US8992916 B2 for clone 01951/G12 [1]. |
Immunopharmacology Disease | |||
Disease | X-Refs | Comment | References |
Crohn's disease |
Disease Ontology:
DOID:8778 OMIM: 266600 Orphanet: ORPHA206 |
Phase 2 trial NCT01316601 in CD has been completed. | |
Asthma |
Disease Ontology:
DOID:2841 OMIM: 600807 |
Phase 2 trial NCT01479595 in asthma has been completed. | |
Allergic rhinitis |
Disease Ontology:
DOID:4481 |
Phase 2 trial NCT00584584 in allergic rhinitis has been completed. | |
Eosinophilic esophagitis |
Disease Ontology:
DOID:13922 Orphanet: ORPHA73247 |
Phase 2 trial NCT01022970 in eosinophilic esophagitis has been completed. |